LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences. Selecta is a clinical-stage biopharmaceutical company focused on utilizing its Synthetic Vaccine Particle (SVP) platform to develop biologic therapies for rare and serious diseases that avoid the immune responses that compromise efficacy and lead to life-threatening complications. To support the development of these products, LSNE will provide drug substance manufacturing and fill/finish services. ...